Avastin

Poor test results for Roche cloud growth prospects
Poor test results for Roche cloud growth prospects
Yahoo/Reuters
Roche
biosimilars
Rituxan
Herceptin
Avastin
Flag link:
The biosimilar pack is growing around Roche’s all-star trio, looking to rip into a $21B franchise
The biosimilar pack is growing around Roche’s all-star trio, looking to rip into a $21B franchise
Endpoints
Roche
biosimilars
Avastin
Herceptin
ABP 215
Amgen
MYL-14010
Mylan Labs
Rituxan
Flag link:
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
prescription data
Sanofi
Lantus
Roche
Herceptin
Avastin
Celgene
Revlimid
JNJ
Merck
Remicade
Biogen
Rituxan
Amgen
Enbrel
Gilead Sciences
Harvoni
AbbVie
Humira
Flag link:
Amid sales growth, Roche plans defense from biosimilar threats
Amid sales growth, Roche plans defense from biosimilar threats
BioPharma Dive
Roche
biosimilars
Rituxan
Herceptin
Avastin
Flag link:
3 Big Biotech Stocks With Big-Time Catalysts
3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Regeneron
Praluent
Amgen
biosimilars
Amjevita
Humira
ABP-215
Avastin
ABP-980
Herceptin
Celgene
ozanimod
Flag link:
The 19 Best-Selling Prescription Drugs of All-Time
The 19 Best-Selling Prescription Drugs of All-Time
Motley Fool
Lipitor
Humira
Seretide
Remicade
Plavix
Enbrel
Rituxan
Herceptin
Avastin
Nexium
Zyprexa
Flag link:
The Demise of the BPCIA Patent Dance?
The Demise of the BPCIA Patent Dance?
FDA Law Blog
BPCIA
patents
Genentech
Amgen
Sandoz
Avastin
Flag link:
Amgen and the BPCIA Patent Dance – Redux
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Amgen
patents
BPCIA
FDA
Sandoz
Neupogen
generics
Genentech
Avastin
Flag link:
Amgen, Allergan Seek EU OK for Avastin Biosimilar
Amgen, Allergan Seek EU OK for Avastin Biosimilar
Investopedia
Amgen
Allergan
Avastin
biosimilars
Europe
ABP 215
non-squamous lung cancer
Flag link:
Amgen, Allergan step up to challenge Roche's Avastin with FDA biosim filing
Amgen, Allergan step up to challenge Roche's Avastin with FDA biosim filing
Fierce Pharma
Amgen
Allergan
Roche
Avastin
biosimilars
FDA
ABP 215
Flag link:
Roche adjusts Avastin franchise defense plans as PhII successor fails a key study
Roche adjusts Avastin franchise defense plans as PhII successor fails a key study
Endpoints
Roche
Avastin
Vanucizumab
Flag link:
Roche rules out quality problems with Avastin in India
Roche rules out quality problems with Avastin in India
BioPharma Dive
Roche
Avastin
India
off-label
Flag link:
India reclears Roche's Avastin for off-label eye sales
India reclears Roche's Avastin for off-label eye sales
Fierce Pharma Marketing
India
Roche
Avastin
off-label
Flag link:
Roche's pharma chief sees no 'short term' pricing pressure on its cancer blockbusters
Roche's pharma chief sees no 'short term' pricing pressure on its cancer blockbusters
Fierce Pharma
Roche
drug pricing
Rituxan
Avastin
Herceptin
Flag link:
Off-label use of Avastin in India hospitalizes 15, sales halted in two states
Off-label use of Avastin in India hospitalizes 15, sales halted in two states
BioPharma Dive
Avastin
India
off-label
Roche
wet age-related macular degeneration
Flag link:
Biosimilars Are Coming After Big Pharma's Bottom Line
Biosimilars Are Coming After Big Pharma's Bottom Line
Fortune
Big Pharma
biosimilars
Roche
AbbVie
MabThera
Herceptin
Avastin
Humira
Janssen
Remicade
Flag link:
Roche CEO Slams `Stupid' U.K. Decision to Drop Some Cancer Drugs
Roche CEO Slams `Stupid' U.K. Decision to Drop Some Cancer Drugs
Bloomberg
Roche
Pharma CEOs
UK
cancer
Avastin
Severin Schwan
Flag link:
Eylea erodes Lucentis, Avastin market share
Eylea erodes Lucentis, Avastin market share
Medical Marketing and Media
Eylea
Lucentis
Avastin
Regeneron
Roche/Genentech
Flag link:
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
biosimilars
AbbVie
Roche
Amgen
Rituxan
Herceptin
Avastin
Neupogen
Neulasta
Epogen
Humira
Perjeta
Gazyva
Flag link:
Did Novartis try to sabotage Avastin ophthalmic trials?
Did Novartis try to sabotage Avastin ophthalmic trials?
BioPharma Dive
Novartis
Avastin
Roche
Lucentis
Flag link: